GSK has completed 0 recorded acquisitions and 3 divestitures or spin-offs, spanning 2013 to 2022.
| Date | Type | Assets | Counterparty | Value |
|---|---|---|---|---|
| Jul 2022 | Spin-off | Sensodyne, Panadol, Voltaren and Centrum +4 | Haleon | — |
| Nov 2019 | Acquisition (sold) | Prevacid 24HR | Perrigo | $61.5m |
| Dec 2013 | Acquisition (sold) | Lucozade and Ribena | Suntory | £1.35bn |
GSK demerged its consumer healthcare business as Haleon, listing it in London and New York in July 2022. The business already contained Pfizer's consumer health portfolio, contributed to a joint venture in 2019, which is how Advil and Centrum came to sit alongside Sensodyne and Panadol.
Perrigo bought the branded over-the-counter rights to Prevacid 24HR from GlaxoSmithKline for $61.5 million in cash, capitalising $61.7 million including closing costs as a brand intangible and amortising it over twenty years. What changed hands was the right to sell the brand over the counter rather than the underlying drug, which is how most of Perrigo's branded portfolio has been assembled.
GlaxoSmithKline sold the Lucozade and Ribena business, including the Coleford manufacturing site in Gloucestershire and related inventory, to Suntory Beverage & Food for 1,352 million pounds in cash. GSK booked a profit on disposal of 1,057 million pounds and said the brands would grow better under an owner with drinks distribution in emerging markets. Suntory put them into a new company, Lucozade Ribena Suntory, which began trading in 2014.
Ownership recorded here as having ended, whether or not a deal record with a filing behind it exists for the transfer.
| Brand | Owned from | Until | Owner today |
|---|---|---|---|
| Sensodyne | Dec 2000 | Jul 2022 | Haleon |
| Panadol | Dec 2000 | Jul 2022 | Haleon |
| Polident | Dec 2000 | Jul 2022 | Haleon |
| Parodontax | Dec 2000 | Jul 2022 | Haleon |
| Voltaren | Mar 2015 | Jul 2022 | Haleon |
| Otrivin | Mar 2015 | Jul 2022 | Haleon |
| Centrum | Aug 2019 | Jul 2022 | Haleon |
| Advil | Aug 2019 | Jul 2022 | Haleon |
Brandtree needs to remember this choice and does not set any other cookie unless you accept.
If you choose “Accept all”, we also use Google Analytics cookies to count visits and see which pages help, so we can improve the site.
If you choose “Accept required”, no analytics cookie is set. Google Analytics still receives a cookieless ping with the page address and your IP address. No advertising is used either way. Privacy policy